STRIDES PHARMA SCIENCE LIMITED — AGM Information 2025

Aug 7, 2025

August 7, 2025

The BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001.

Scrip Code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051.

Scrip Code: STAR

Dear Madam/ Sir,

Sub : Proceedings of the 34[th] Annual General Meeting (AGM) of the Company

We wish to inform you that the 34[th] AGM of the Company was held on Thursday, August 7, 2025 at 11:30 hrs IST through video conference and ended at 13:03 hrs IST.

Pursuant to Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed summary of proceedings of the AGM.

This is for your information and records.

Thanks & Regards,

For Strides Pharma Science Limited

MANJ Digitally signed by MANJULA R Date: 2025.08.07 ULA R 14:38:47 +05'30'

Manjula Ramamurthy Company Secretary ICSI Membership No.: A30515

Encl. as above

Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199 corpcomm@strides.com; www.strides.com

SUMMARY OF PROCEEDINGS OF 34[TH ] ANNUAL GENERAL MEETING OF THE COMPANY HELD ON THURSDAY, AUGUST 7, 2025, FROM 11:30 HRS IST TO 13:03 HRS IST THROUGH VIDEO CONFERENCE.

Ms. Manjula Ramamurthy, Company Secretary of the Company, welcomed the Shareholders to the 34[th] Annual General Meeting (‘AGM’) of the Company, which was held through video conference and in compliance with the applicable provisions of the Companies Act, 2013 read with the Rules framed thereunder, Secretarial Standard-2, Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and various applicable Circulars issued by MCA and SEBI in this regard.

Thereafter, Manjula introduced Board Members and other Invitees present at the meeting to the Shareholders and the following was noted:

Present:

Name	Designation
Mr. Arun Kumar	Founder and Non-Executive Chairperson
Dr. Kausalya Santhanam	Independent Director and
	Chairperson of CSR Committee and Stakeholders’ Relationship
	Committee
Ms. Mukta Arora	Independent Director
Mr. Homi Khusrokhan	Independent Director and
	Chairperson of Audit Committee and Risk Management
	Committee
Mr. Ameet Hariani	Independent Director and
	Chairperson of Nomination and Remuneration Committee
Mr. Subir Chakraborty	Independent Director
Mr. Badree Komandur	Managing Director and Group CEO
Mr. Aditya Arun Kumar	Executive Director – Business Development
Mr. Vikesh Kumar	Group CFO

Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199 corpcomm@strides.com; www.strides.com

Other Invitees present at the meeting were noted as under:

Mr. G PrakashMs. Priyanka Biswas	From B S R & Co. LLP,Chartered Accountants,Statutory Auditors of the Company
Mr. Anup Thomas	From Grant Thornton Bharat LLP,Internal Auditors of the Company
Mr. Gopalakrishna Raj H H	Secretarial Auditor
Mr. Gigi Joseph K J	Partner of M/s. Joseph and Chacko LLP,Company Secretaries, BengaluruScrutinizer for E-voting Process

Thereafter, Kfin Technologies Limited (Kfin/ RTA) confirmed presence of requisite quorum for the meeting.

Mr. Arun Kumar chaired and called the meeting to order. Arun greeted the Shareholders and requested Mr. Badree Komandur to brief the Shareholders on Company’s performance for the financial year ended March 31, 2025, amongst other matters.

Thereafter, Mr. Badree Komandur provided performance update to the Shareholders.

Post Badree’s presentation, Speaker Shareholders who had registered with the Company for speaking at the AGM were provided an opportunity to express their views/ ask their queries about the Company and Agenda Items of the AGM.

Queries were adequately responded by Mr. Badree Komandur and Mr. Aditya Arun Kumar.

As AGM Notice and Annual Report for FY25 were already circulated to all Shareholders, AGM Notice convening the meeting, Board’s Report and Auditor’s Report were taken as read.

Shareholders were informed that:

• 1. Auditor’s Report for the Consolidated and Standalone statements of the Company for the financial year ended March 31, 2025, does not contain any qualification, observations or adverse comments.
• 1. Requisite Statutory Registers and other documents referred to in the AGM Notice were available for inspection electronically by the Shareholders.
• 1. Certificate from Secretarial Auditor of the Company, certifying that the existing ESOP Scheme of the Company have been implemented in accordance with SEBI Regulations and in line with Shareholders’ approval, was also available for e-inspection.

Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199

corpcomm@strides.com; www.strides.com

Thereafter, following items of business as mentioned in the AGM Notice were transacted at the meeting:

#	Resolutions Description	Type of
		Resolution
Ordinary Business
1	Adoption of Audited Financial Statements for the Financial Year ended March31, 2025	Ordinary
2	Declaration of Final Dividend for the Financial Year ended March 31, 2025	Ordinary
3	Re-appointment of Mr. Aditya Arun Kumar, retiring Director	Ordinary
Special Business
4	Appointment of M/s V. Sreedharan & Associates, as Secretarial Auditor of theCompany	Ordinary
5	Remuneration payable to M/s. Rao, Murthy & Associates, Cost Auditors ofthe Company for FY 2025-26	Ordinary

Shareholders were informed that insta voting facility is available for those shareholders who have not voted during the remote e-voting period. Accordingly, Shareholders were given the facility to vote on the Kfin platform for the next 30 minutes.

Shareholders were informed that e-voting results along with Scrutinizer’s Report would be declared within two working days of conclusion of the AGM i.e on or before Monday, August 11, 2025.

Thereafter, meeting ended with a vote of thanks by the Chairperson.

For Strides Pharma Science Limited,

MANJ Digitally signed by MANJULA R Date: 2025.08.07 ULA R 14:39:23 +05'30'

ULA R 14:39:23 +05'30' Manjula Ramamurthy Company Secretary ICSI Membership No.: A30515

Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199

corpcomm@strides.com; www.strides.com